2024-11-20 16:28:20
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets
Health/ 2023-07-22
ENSEM Therapeutics, a CBC Group-Incubate...

BOSTON,April 7,2022--ENSEM Therapeutics Inc. (ENSEM),a Boston-based biotechnology company focusing on high value and difficult-to-drug oncol...

Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022
Corporate/ 2023-07-24
Harbour BioMed Announces Global Out-Lice...

CAMBRIDGE,Mass. and ROTTERDAM,Netherlands andSUZHOU,China,April 7,2022--Harbour BioMed ("HBM","the Company",HKEX: 02142)...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release